A Comprehensive Review of HER2 in Cancer Biology and Therapeutics

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations

Abstract

Human epidermal growth factor receptor 2 (HER2), a targetable transmembrane glycoprotein receptor of the epidermal growth factor receptor (EGFR) family, plays a crucial role in cell proliferation, survival, and differentiation. Aberrant HER2 signaling is implicated in various cancers, particularly in breast and gastric cancers, where HER2 overexpression or amplification correlates with aggressive tumor behavior and poor prognosis. HER2-activating mutations contribute to accelerated tumorigenesis and metastasis. This review provides an overview of HER2 biology, signaling pathways, mechanisms of dysregulation, and diagnostic approaches, as well as therapeutic strategies targeting HER2 in cancer. Understanding the intricate details of HER2 regulation is essential for developing effective targeted therapies and improving patient outcomes.

Original languageEnglish
Article number903
JournalGenes
Volume15
Issue number7
DOIs
StatePublished - Jul 2024

Keywords

  • ADC
  • cancer
  • HER2
  • immune regulation
  • metastasis
  • therapeutics

Fingerprint

Dive into the research topics of 'A Comprehensive Review of HER2 in Cancer Biology and Therapeutics'. Together they form a unique fingerprint.

Cite this